Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herman

Showing results (1111-1120 of 1,237) with videos related to

Pageof 124
Sort By:
Annals of Surgery|January 16, 2018
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?Jin He, Alex B Blair, Vincent P Groot, et al.
American Journal of Clinical Oncology|February 24, 2017
ACR Appropriateness Criteria® Resectable Pancreatic CancerWilliam E Jones, W Waren Suh, May Abdel-Wahab, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal CancerSuzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
The American Journal of Surgical Pathology|February 1, 2024
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor LesionsYen-Wei Chien, Yeh Wang, Peng Huang, et al.
Cancer Medicine|February 10, 2022
High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapyColin Hill, Shuchi Sehgal, Wei Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian CarcinomaBeryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, et al.
Human Pathology|October 6, 2009
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patientsK Ranh Voong, Jon Davison, Timothy M Pawlik, et al.
International Journal of Surgical Oncology|August 31, 2012
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visitsSalma K Jabbour, Shyamal Patel, Joseph M Herman, et al.
Haematologica|October 3, 2015
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinibAndrew H Lipsky, Mohammed Z H Farooqui, Xin Tian, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Pageof 124

Showing results (1111-1120 of 1,237) with videos related to

Sort By:
Pageof 124
Annals of Surgery|January 16, 2018
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?Jin He, Alex B Blair, Vincent P Groot, et al.
American Journal of Clinical Oncology|February 24, 2017
ACR Appropriateness Criteria® Resectable Pancreatic CancerWilliam E Jones, W Waren Suh, May Abdel-Wahab, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal CancerSuzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
The American Journal of Surgical Pathology|February 1, 2024
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor LesionsYen-Wei Chien, Yeh Wang, Peng Huang, et al.
Cancer Medicine|February 10, 2022
High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapyColin Hill, Shuchi Sehgal, Wei Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian CarcinomaBeryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, et al.
Human Pathology|October 6, 2009
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patientsK Ranh Voong, Jon Davison, Timothy M Pawlik, et al.
International Journal of Surgical Oncology|August 31, 2012
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visitsSalma K Jabbour, Shyamal Patel, Joseph M Herman, et al.
Haematologica|October 3, 2015
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinibAndrew H Lipsky, Mohammed Z H Farooqui, Xin Tian, et al.
BMC Cancer|July 29, 2017
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreasMatthew H G Katz, Fang-Shu Ou, Joseph M Herman, et al.
Pageof 124